← Leaderboards
Daniel Pevear
Venatorx Pharmaceuticals, Inc.
$25,064,821
Attributed
$25,064,821
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $9.4M · FY2020–25$10M$7.5M$5M$2.5M$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$25,064,821 · 1
By mechanism
N01$25,064,821 · 1
Top collaborators
No co-investigators on record.
Most similar at Venatorx Pharmaceuticals, Inc.
Same institution · by research overlap
- Luigi Xerri$39,662,982
- Timothy Henkel$48,583,055
- Steven Armen Boyd$13,685,544
- Denis Marc Daigle$7,512,530
- Bin Liu$3,147,000
Others in their field
Other Emerging Leaders on “Advanced Development”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Leonard Freedman · Leidos Biomedical Research, Inc.$378,174,673
- Chanza Baytop · Westat, Inc.$271,217,917
- Valerie Koch · University Corporation For Atmospheric Res$243,972,016
- Joel A Lipkin · Four Points Technology, Llc$181,896,915
- Kimberly Smith · Ppd Development Lp$115,671,664
Research focus
Advanced DevelopmentBacterial Antibiotic ResistanceChemistryPre-ClinicalProduct DevelopmentResearch And DevelopmentTherapeutic CandidateTherapeutic DevelopmentEfficacy EvaluationSafety AssessmentPathway InteractionsEmerging Communicable DiseasesManufactureBacterial ResistanceBiodefenseCandidate SelectionClinical AssessmentsLead OptimizationResearch SupportCombating Antibiotic Resistant BacteriaPathogenBacterial Drug ResistanceInvestigational New Drug ApplicationNational Institute Of Allergy And Infectious Disease
Grant awards (5)
Development of Therapeutic Products for Antibiotic Resistant Bacteria$275,793
N01 · FY2025 · AI · contact PI
Development of Therapeutic Products for Antibiotic Resistant Bacteria$9,407,873
N01 · FY2024 · AI · contact PI
Development of Therapeutic Products for Antibiotic Resistant Bacteria$4,711,879
N01 · FY2023 · AI · contact PI
Development of Therapeutic Products for Antibiotic Resistant Bacteria$7,440,148
N01 · FY2022 · AI · contact PI
Development of Therapeutic Products for Antibiotic Resistant Bacteria$3,229,128
N01 · FY2020 · AI · contact PI